Open AccessCorrection: Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial
Author(s) -
Katherine A. Sutherland,
Chris M. Parry,
Adele McCormick,
Anne Kapaata,
Fred Lyagoba,
Pontiano Kaleebu,
Charles F. Gilks,
Ruth Goodall,
Moira J. Spyer,
Cissy Kityo,
Deenan Pillay,
Ravindra K. Gupta
Publication year - 2016
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0157094
Subject(s) - protease , protease inhibitor (pharmacology) , medicine , correct name , pharmacology , bioinformatics , biology , virology , enzyme , biochemistry , paleontology , human immunodeficiency virus (hiv) , viral load , antiretroviral therapy
[This corrects the article DOI: 10.1371/journal.pone.0137834.]
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom